Virtus LifeSci Biotech Products ETF (BBP): Price and Financial Metrics ETF
BBP Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $53.34 | 52-week high | $55.22 |
| Prev. close | $53.19 | 52-week low | $35.35 |
| Day low | $53.20 | Volume | 1,760 |
| Day high | $53.44 | Avg. volume | 1,488 |
| 50-day MA | $51.55 | Dividend yield | N/A |
| 200-day MA | $49.37 |
BBP Stock Price Chart Interactive Chart >
Virtus LifeSci Biotech Products ETF (BBP) ETF Bio
The investment objective of the Virtus LifeSci Biotech Products ETF seeks investment results that correspond to the price and yield performance of the BioShares Biotechnology Products Index. The products index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate that has received U.S. Food and Drug Administration approval.
BBP ETF Info
| Issuer | Virtus ETF Advisors LLC |
| Expense Ratio | 0.79% |
| Underlying Index | LifeSci Biotechnology Products Index |
| Asset Class | Portfolio-Multi Asset |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 18.13M |
| Net Asset Value (NAV) | $51.80 |
| Options? | Yes |
| Total Holdings | 60 |
BBP Top Holdings
| Symbol | Company | % of Total |
| IMGN | ImmunoGen Inc | 4.84% |
| AUPH | Aurinia Pharmaceuticals Inc | 3.45% |
| APLS | Apellis Pharmaceuticals Inc | 2.93% |
| CTIC | CTI BioPharma Corp | 2.72% |
| ACAD | ACADIA Pharmaceuticals Inc | 2.67% |
| SGEN | Seagen Inc | 2.61% |
| BBIO | Bridgebio Pharma Inc | 2.59% |
| MIRM | Mirum Pharmaceuticals Inc | 2.56% |
| ROIV | Roivant Sciences Ltd | 2.29% |
| LEGN | Legend Biotech Corp | 2.17% |
BBP Price Returns
| 1-mo | -0.69% |
| 3-mo | 8.14% |
| 6-mo | 7.21% |
| 1-year | 37.74% |
| 3-year | 16.65% |
| 5-year | 21.37% |
| YTD | 8.24% |
| 2022 | 0.85% |
| 2021 | -8.17% |
| 2020 | 22.24% |
| 2019 | 24.73% |
| 2018 | -13.95% |